Final Program

MONDAY • MAY 16 203
P588
P589
Facilitator:
P590
P591
P592
P593
P594
P595
P596
P597
High Neutropil-Lymphocyte Ratio Confers Poor Prognosis in
Patients with Small Cell Lung Cancer/D. Liu, W. Li, Chengdu,
China, p.A4269
The Difference of Survival Time of the Patients with Thoracic
Malignancy According to Timing of Consultation to Palliative
Care Doctor/T. Okimoto, Y. Tsubata, R. Tanino, Y. Mori, Y.
Amano, M. Nakao, T. Hotta, N. Koba, M. Hamaguchi, S.
Hamaguchi, T. Hoshino, A. Sutani, Y. Awaya, H. Takeyama, T.
Isobe, Izumo, Japan, p.A4270
T. Peikert, MD, Rochester, MN
Evaluation of the Clinical Outcomes of Advanced Non-Small
Cell Lung Cancer Patients with Actionable Mutations Treated
with Molecular Targeted Therapy in the Intensive Care
Unit/K.C. Kerrigan, G. Otterson, Columbus, OH, p.A4271
Impact of Chronic Hepatitis C Infectionand Liver Metastasis on
Survival Outcome of EGFR Mutation-Positive Advanced
Non-Small-Cell Lung Cancer (NSCLC) Patient Treated with
First-Line Gefetinib in Real-World Practice/Z.-H. Yao, W.-Y.
Liao, C.-C. Ho, K.-Y. Chen, J.-Y. Shih, J.-S. Chen, Z.-Z. Lin, C.-C.
Lin, J.C.-H. Yang, C.-J. Yu, Taipei, Taiwan, p.A4272
Influence of Diagnosis and Treatment Delays on Survival of
Lung Cancer/M.A. Solis, J. Falco, A.R. Garcia, M. Heres, S. Lamot,
M. Hernandez, S. Quadrelli, Buenos Aires, Argentina, p.A4273
Does Smoking Status After a Diagnosis of Lung Cancer Matter?
The Effect of Quitting on Patient Outcomes/R.E. Roberts, K.
Lewis, R. Ghosal, G. Collier, Llanelli, United Kingdom, p.A4274
The Efficacy of Bevacizumab for Patients with Malignant
Pleural Effusion or Ascites: A Meta-Analysis from 6
Randomized Controlled Clinical Trials/J. Zhang, Shanghai,
China, p.A4275
The Degree of Emphysema and Air Trapping Detected by
Quantitative Computed Tomography Predicts Lung Cancer
Survival/M.A. Moughrabieh, W. Chen, C. Lusk, A. Wenzlaff, H.
Jang, C. Neslund-Dudas, D.L. Spizarny, T. Song, M. Flynn, A.
Soubani, S. Gadgeel, A. Schwartz, Detroit, MI, p.A7848
Moderate Centrilobular Emphysema Is the Lung Parenchymal
Morphology Associated with A Risk for Lung Cancer/C.M.
Kinsey, C. Mendoza, B. Cole, J.H.T. Bates, R.P. Bowler, G.
Washko, R.S.J. Estepar, Burlington, VT, p.A7849
The Impact of Mental Health Comorbidities on Timeliness of
Care in Veterans with Lung Cancer/S.S. Khatami, S. Takemoto,
S. Wang, N. Trivedi, San Francisco, CA, p.A7850
Monday Mid-day, May 16
11:45 a.m. - 1:15 p.m.
S3 ATS WOMEN’S FORUM
SAN FRANCISCO MARRIOTT MARQUIS
Yerba Buena Salon 7 (Lower B2 Level)
The annual ATS Women's Forum recognizes the achievements and
supports the advancement of women in pulmonary, critical care, and sleep
medicine and research. At the forum Catherine R. Lucey, MD, Professor
of Medicine, Vice Dean for Education, University of California San
Francisco School of Medicine will discuss issues that are relevant to
female medical professionals followed by a question and answer period.
In addition, the 2016 Elizabeth A. Rich, MD Award, which has honored the
work and memory of Elizabeth Rich, MD since 2000, will be presented.
The award is given to a woman who has made significant achievements in
the practice or science of pulmonary, critical care, or sleep medicine;
demonstrated leadership in her field; and has shown dedicated
mentorship of junior colleagues. The 2016 award recipient is Irina
Petrache, MD, Professor, Department of Medicine, Chief, Pulmonary,
Critical Care and Sleep Medicine, National Jewish Health, Denver, CO.
Dr. Petrache will also address the audience.
The forum provides a valuable opportunity for women to meet new
colleagues and ATS leaders. Men are also welcome to attend the forum.
Attendees will find value in the inspirational messages and career insights
that the speakers share as well as vibrant networking opportunities.
The forum is organized and presented by the ATS Membership
Committee, and will be hosted by Yolanda Mageto, MD, MPH, chair of
the committee.
Conference badges are required for admission.
Space is limited and admittance is on a first-come, first-served basis.
There is no additional fee. A plated lunch will be served.
MONDAY MID-DAY
The information contained in this program is up to date as of March 9, 2016.
For the most current session information, please visit the online program itinerary.
ATS 2016 • San Francisco